Search our data
Search for chemicals / regulated substances

Search for articles (products) in SCIP database

News

PIC
Trade in products containing benzene increased EU imports of hazardous chemicals
20/12/2023

The reported volume of hazardous chemicals imported to and exported from the European Union (EU) under the Prior Informed Consent (PIC) Regulation continued to increase in 2022.

REACH
CLP
Hazardous chemicals found in many consumer products
13/12/2023

An EU-wide enforcement project of the ECHA Forum found excessive levels of hazardous chemicals, such as lead and phthalates, in products that are sold to consumers. In total 18 % of the inspected products breached the EU laws.

REACH
CLP
Highlights from November RAC and SEAC meetings
07/12/2023

The Committee for Socio-Economic Analysis (SEAC) adopted its opinion supporting France’s proposal to restrict creosote and related substances. The Committee for Risk Assessment (RAC) adopted eight opinions on harmonised classification and labelling. One of these concerns tea-tree oil, where the committee recommends adding reproductive toxicity as the most stringent classification.

Events

Shaping Tomorrow Conference 2024
28/02/2024 | Helsinki/Online

Webinars home page

Webinars

IUCLID 6 October 2023 release
21/11/2023 | 11:00 - 13:00 (EET, GMT +2)

 

 

 

 

 

Consultations

REACH

Calls for comments and evidence
Substances: 1
  • Start date: 15/11/2023
  • Deadline: 12/02/2024
Substances: 1
  • Start date: 13/12/2023
  • Deadline: 13/02/2024
Testing proposals
Testing proposals: 17
  • Start date: 04/12/2023
  • Deadline: 18/01/2024

CLP

Harmonised classification and labelling
CLH proposals: 4
  • Start date: 20/11/2023
  • Deadline: 19/01/2024
CLH proposals: 1
  • Start date: 11/12/2023
  • Deadline: 09/02/2024

BPR

Potential candidates for substitution
Active substance: 1
  • Start date: 21/11/2023
  • Deadline: 22/01/2024

CAD/CMRD

Consultations on OEL proposal
OEL proposals: 1
  • Start date: 19/12/2023
  • Deadline: 19/02/2024

POPs

There are currently no ongoing consultations.